T56-LIMKi
T56-LIMKi is a selective inhibitor of LIMK2; inhibits the growth of Panc-1 cells with an IC50 of 35.2 μM.
Product Specifications
CAS Number
924473-59-6
Product Name Alternative
T5601640
UNSPSC
12352005
Hazard Statement
H301, H413
Target
LIM Kinase (LIMK)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/T56-LIMKi.html
Purity
98.67
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(C)=NO1)NC2=CC=CC(C(NC3=CC=CC(C(F)(F)F)=C3)=O)=C2
Molecular Formula
C19H14F3N3O3
Molecular Weight
389.33
Precautions
H301, H413
References & Citations
[1]Rak R, et al. Novel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft model. Oncoscience. 2014 Jan 1;1 (1) :39-48. eCollection 2014.|[2]Mashiach-Farkash E, et al. Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton. Oncotarget. 2012 Jun;3 (6) :629-39.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
LIMK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![1- (1-phenylethyl) -1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
sc-332021A 1 g
1- (1-phenylethyl) -1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid
Sign In for Pricing
View Details 
